Genomate Health

Genomate Health Genomate Health is a digital health company that develops computational solutions for personalized medicine.

A cancer diagnosis often brings more questions than answers. Understanding the disease, evaluating treatment options, an...
08/27/2026

A cancer diagnosis often brings more questions than answers. Understanding the disease, evaluating treatment options, and making difficult decisions can feel overwhelming for both patients and those who care for them.

Support can come from many places: family, friends, healthcare professionals, patient advocacy groups, and access to clear, reliable information.

At Genomate Health, we believe that knowledge is a form of support. Helping patients and their care teams better understand the complete molecular profile of a tumor can contribute to more informed conversations and greater confidence in treatment decisions.

This World Cancer Support Month, we recognize everyone who stands beside a person living with cancer, every step of the way.

Precision oncology is global. So the conversation around it should be, too. Today, that conversation takes us to India.I...
08/07/2026

Precision oncology is global. So the conversation around it should be, too. Today, that conversation takes us to India.

Istvan Petak MD, PhD, Founder & CSO of Genomate Health, joins , as the ISO Indian Society of Oncology brings together clinicians, researchers and leaders around a theme very close to our work: "Collaborative Oncology with Precision."

Because precision isn’t only about finding more data. It’s about making sense of what we know, bringing the right expertise together, and turning complexity into better treatment decisions for patients.

Different countries. Different healthcare systems. One increasingly shared challenge: how do we make precision oncology work for more patients, in the real world?

If you’re attending, we look forward to connecting. See you at , August 7–9.

08/01/2026

Every year, millions of people around the world hear the words, "You have lung cancer."
Sadly, that number is expected to rise in the decades ahead. According to the Global Cancer Observatory, the annual number of new lung cancer cases is projected to increase from 2.64 million in 2024 to 4.61 million by 2050.

Behind every one of those numbers is a person, a family, and a series of critical treatment decisions.

But lung cancer is not one disease.

Patients with the same diagnosis can have completely different molecular profiles, meaning they may respond very differently to the same treatment. That's why comprehensive biomarker testing has become a cornerstone of modern lung cancer care.

Understanding the biology of each individual tumor helps identify targeted therapies, immunotherapies, and clinical trials that may offer the greatest benefit.

At Genomate Health, we're working to help clinicians and patients make more informed treatment decisions by analyzing the complete molecular context of every tumor.

Because every patient deserves a treatment plan as unique as their cancer.

Some of the most meaningful advances in precision oncology begin with a simple question: What are we still missing?After...
07/27/2026

Some of the most meaningful advances in precision oncology begin with a simple question: What are we still missing?

After three years of collaboration, the Eurostars-funded Genomic Noise Cancelling (GNC) consortium has completed its research project, exploring how computational approaches can help distinguish clinically meaningful molecular signals from the background complexity of cancer biology.

The project combined advanced bioinformatics, computational reasoning, and clinical expertise to improve how complex molecular profiling results are interpreted. By reducing irrelevant findings while preserving biologically meaningful information, this work has the potential to reveal treatment opportunities that might otherwise be overlooked.

While the project has now concluded, its impact continues. The knowledge, technology, and collaborations established through GNC are already helping shape the next generation of precision oncology tools and supporting more informed treatment decisions for cancer patients.

We're grateful to our partners, researchers, clinicians, and the Eurostars programme for making this collaboration possible: Euformatics, Christophe Roos, Abhilash Nair, Ph.D., Jukka Matilainen, Tommi Kaasalainen, Institut Curie, Edith Borcoman, Célia Dupain (Tresfield), Kenza Nedara, PhD, Nicolas Servant, Genomate Health, Oncompass Medicine, Barbara Vodicska, PhD, Enikő Kispéter, Istvan Petak MD, PhD

Read the full announcement: https://www.genomate.health/news-article/eurostars-consortium-completes-precision-oncology-project-that-could-reveal-overlooked-treatment-options-for-cancer-patients

Most of us know that too much sun can damage our skin. Fewer people realize just how significant that damage can be.Acco...
07/22/2026

Most of us know that too much sun can damage our skin. Fewer people realize just how significant that damage can be.

According to research from the International Agency for Research on Cancer (IARC), more than 80% of melanoma cases worldwide are attributable to UV radiation. That's an estimated 267,000 of 332,000 cases in a single year.

Reducing UV exposure is one of the most effective ways to lower your risk. But prevention is only part of the story.

If skin cancer is diagnosed, it's important to remember that melanoma is not a single disease. Two patients may receive the same diagnosis yet require entirely different treatment approaches because the molecular drivers of their tumors are different.

Understanding the biology of an individual tumor can help reveal:
↗ The genetic alterations driving cancer growth
↗ Potential resistance mechanisms
↗ Which therapies may be more or less likely to benefit that specific patient

Cancer treatment decisions are strongest when they're guided not only by where a cancer starts, but by what is driving it.

If you or someone you care about is facing a skin cancer diagnosis, asking whether you've built the most complete picture of the tumor can be an important part of making informed treatment decisions. Learn more about our Second Opinion service: https://genomate.health/services/second-opinion?utm_source=social&utm_medium=organic&utm_campaign=skin

"Some of the most important scientific discoveries begin with observations that challenge existing biological assumption...
07/16/2026

"Some of the most important scientific discoveries begin with observations that challenge existing biological assumptions." — Istvan Petak MD, PhD

That's the idea behind our new research collaboration with Inflexa.

Together, we're aiming to advance precision medicine through complementary computational approaches. Genomate Health's platform integrates genomic alterations and their biological interactions to prioritize therapies, while Inflexa's technology analyzes multiple layers of omics data to uncover novel biomarkers and biological pathways.

Read more in 's coverage of the collaboration:
https://lnkd.in/dEz98xG6

After a cancer diagnosis, every treatment decision carries weight. For many patients, traveling to a major cancer center...
07/08/2026

After a cancer diagnosis, every treatment decision carries weight. For many patients, traveling to a major cancer center for another opinion simply isn't possible.

That's why we built Genomate's Second Opinion Service.

By combining computational analysis of your tumor's complete molecular profile with review from precision oncology experts, we help you better understand your diagnosis, confirm your treatment plan, and explore additional options that may be available, including targeted therapies and clinical trials.
Because peace of mind comes from knowing you've explored every relevant option.

Learn more: https://lnkd.in/dcWkYn6P

This , we're reminded that behind every lung cancer diagnosis is a person whose treatment decisions deserve the most co...
06/29/2026

This , we're reminded that behind every lung cancer diagnosis is a person whose treatment decisions deserve the most complete understanding possible.

Lung cancer is not defined by a single mutation. Every tumor is shaped by a unique combination of genetic alterations that interact in ways that can influence which treatments are more (or less) likely to work.

At Genomate Health, understanding that complexity has been at the heart of our research. We use computational reasoning to analyze the complete molecular profile of a patient's cancer, helping identify treatment opportunities, resistance patterns, and clinically relevant insights that may not be apparent when looking at individual biomarkers alone.

Our published lung cancer research includes:
• Treatment efficacy predictivity analysis in the AACR Project GENIE BPC NSCLC cohort: https://www.genomate.health/publication/genomate-treatment-efficacy-predictivity-in-genie-bpc-nsclc-cohort
• Real-world performance analysis in lung cancer: https://www.genomate.health/publication/genomate-real-world-performance-analysis-in-lung-cancer
• A published NSCLC case report demonstrating how comprehensive molecular analysis can support treatment decisions: https://www.genomate.health/publication/case-report-mdpi-nsclc

Together, these studies reflect our commitment to helping transform complex genomic data into clearer, evidence-based insights that support more informed conversations between patients and their oncology teams.

Because every lung cancer case is different. And every patient deserves the most complete understanding possible before making their next treatment decision: https://bit.ly/4uZvyrd

06/25/2026

When facing cancer, it's natural to ask: "Am I on the right treatment?"

Getting a second opinion isn't about questioning your doctor. It's about making one of the most important decisions of your life with as much information as possible.

Today, many second opinions are still based on manually reviewing reports and individual test results. But cancer is rarely driven by a single mutation or one piece of information. A more complete understanding of your tumor can reveal treatment opportunities, explain why certain therapies may or may not work, and provide greater confidence in your next steps.

At Genomate Health, our Second Opinion service combines computational reasoning with expert review to analyze your cancer as a complete biological system, not just a list of genetic alterations.

The result is a clear, personalized report that can help you and your oncologist:
✔ Confirm your current treatment plan
✔ Identify additional treatment options
✔ Understand potential resistance mechanisms
✔ Explore relevant clinical trials

Because when every treatment decision matters, every insight should count. Check if you qualify for a Second Opinion: https://lnkd.in/ebFsTfKd

Immunotherapy has transformed cancer treatment. For some patients, it leads to remarkable, long-lasting responses.And ye...
06/22/2026

Immunotherapy has transformed cancer treatment. For some patients, it leads to remarkable, long-lasting responses.

And yet one of oncology's hardest questions remains: why do some patients respond while others don't?

Rarely is the answer a single biomarker. As oncology generates more molecular data and more sophisticated therapies, the challenge is no longer finding signals, it's understanding how they interact within the biology of each individual cancer.

Tumor biology doesn't work in isolation. Immune interactions, molecular pathways, and cellular behavior all shape treatment response in ways that reductionist approaches often miss.

At Genomate Health, we use computational reasoning to analyze molecular interactions, biological pathways, scientific evidence, and clinical context together, helping oncologists make sense of that complexity and support more informed treatment decisions.

Because the future of precision oncology depends not just on more data, but on understanding the whole cancer. Learn more about how we're helping oncologists navigate cancer complexity at https://www.genomate.health/company/our-technology

Address

Cambridge, MA

Website

Alerts

Be the first to know and let us send you an email when Genomate Health posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Genomate Health:

Shortcuts

Share

Category